BeStock  
Markets › Compare › DMRA vs PGEN

DMRA vs PGEN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
DMRA · Damora Therapeutics$23.22 ▼ 4.44%
PGEN · Precigen$4.21 ▲ 1.20%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

73113153193233Nov 24, '25May 26, '26Nov 20, '26
  • DMRA +42.4%
  • PGEN +10.2%

Head to head

MetricDMRAPGEN
Price$23.22$4.21
Change today▼ 4.44%▲ 1.20%
Market cap$1.44B$1.51B
Return, 3 months-23.4%-41.3%
Return, year to date+0.9%+0.7%
Return, 1 year+38.5%+8.5%
P/E (TTM)13.638.3
P/B3.918.0
P/E percentile vs own 5y99th100th
Dividend yield––
Revenue growth (YoY, latest qtr)–+2,437.6%
Net profit growth (YoY)-921.1%+124.4%
Gross margin–91.4%
Operating margin–21.4%
Net margin–15.6%
Return on equity-156.6%38.8%
Analyst target vs. price+101.0%+232.5%
Analyst buy share100%100%
RSI (14)5432
30-day volatility61.9%117.7%
Max drawdown, 1 year-46.9%-51.4%
Trend readLeaning bullishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • PGEN is the largest of the group by market value.
  • DMRA has returned the most over the past year.
  • DMRA carries the lowest trailing P/E.
  • DMRA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top